Blog
Diversity in Genomic Analysis: An example of how SOPHiA GENETICS has built more accurate health data analysis for diverse populations
Every person is unique. We can clearly see this within the more than one million genomic profiles from 70 different countries analyzed by our technology.
From analysis to confident reporting at the push of a button with OncoPortal Plus
By leveraging expertly curated evidence, powered by JAX-CKB, and SOPHiA GENETICS’ patented algorithms through the SOPHiA DDM platform, users can then use OncoPortal™ Plus to accurately identify clinical associations and actionable biomarker profiles.
US Cancer Moonshot Plan to Cut Cancer Death Rate in Half
The President acknowledged that the US still has much further to come in advancing data-driven initiatives and that many Americans sadly do not realize the struggle of seeking answers during the cancer diagnostic journey until it’s too late.
Major milestones from SOPHiA GENETICS’ biggest year to date
2021 has been a big year for SOPHiA GENETICS. Here’s a recap of some of the major highlights…
Radiomics: 5 Things You Need to Know
Radiomics maximizes upon information that’s already being collected. The difference is how that info is used.
Staying a step ahead of breast cancer with data-driven medicine
About half of all breast cancer patients develop the disease outside of the period of ages 50-69 and could greatly benefit from earlier detection. Today, we know that age alone is not enough to accurately estimate breast cancer risk.
What is the SOPHiA DDM™ universal platform?
Think of it like trying to find a treasure buried on a beach. It would be a lot easier to use a metal detector than to pick through each grain of sand.
